- Home
- DRVN vs GHRS Comparison
DRVN vs GHRS Comparison
Compare DRVN & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DRVN | GHRS |
|---|---|---|
| Founded | 1972 | 2018 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Automotive Aftermarket | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | DRVN | GHRS |
|---|---|---|
| Price | $11.45 | $20.20 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 10 |
| Target Price | $15.26 | ★ $42.89 |
| AVG Volume (30 Days) | ★ 1.1M | 328.5K |
| Earning Date | 11-17-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 146.70 | N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $1,862,438,000.00 | N/A |
| Revenue This Year | $7.59 | N/A |
| Revenue Next Year | $9.17 | N/A |
| P/E Ratio | $21.22 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.80 | $12.04 |
| 52 Week High | $17.30 | $31.44 |
Technical Indicators
Market Signals| Indicator | DRVN | GHRS |
|---|---|---|
| Relative Strength Index (RSI) | 39.31 | 48.74 |
| Support Level | $9.92 | $19.75 |
| Resistance Level | $13.57 | $22.88 |
| Average True Range (ATR) | 0.46 | 1.12 |
| MACD | 0.04 | 0.52 |
| Stochastic Oscillator | 15.51 | 74.18 |
Price Performance
Historical ComparisonAbout DRVN Driven Brands Holdings Inc.
Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes. The company segments; Take 5, Franchise Brands, and Auto Glass Now. It derives maximum revenue from Take 5 Segment. Geographically, the company operates into United States, Canada and Rest of the World.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.